Impact of impaired fasting glucose and other metabolic factors on cognitive function in elderly people P. Di Bonito a, *, L. Di Fraia a , L. Di Gennaro a , A. Vitale a , M. Lapenta a , A. Scala a , M.R. Iardino b , B. Cusati c , L. Attino d , B. Capaldo e a Department of Internal Medicine, ‘‘S. Maria delle Grazie’’ Pozzuoli Hospital, Via Domitiana Loc. La Schiana, 80078 Pozzuoli, Naples, Italy b Department of Clinical Pathology, ‘‘S. Maria delle Grazie’’ Hospital, 80078 Pozzuoli, Naples, Italy c Department of Radiology, ‘‘S. Maria delle Grazie’’ Hospital, 80078 Pozzuoli, Naples, Italy d District 54 ASL Na2, Federico II University, Naples, Italy e Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy Received 20 May 2005; received in revised form 6 July 2005; accepted 6 July 2005 KEYWORDS Cognitive function; Impaired fasting glucose; Homocysteine; Insulin resistance; Diabetes; Dementia Abstract Aim: The present study was undertaken to evaluate the impact of im- paired fasting glucose (IFG), insulin resistance (IR) and hyperhomocysteinaemia (Hhcy) on cognitive function (CF) in a sample of non-diabetic elderly subjects. Methods and results: One hundred and eighty-two non-diabetic subjects, aged 65 years, without signs of previous stroke were included in the study. CF was evaluated by the Mini Mental State Examination (MMSE) score, corrected for age and educa- tion. Since diagnostic criteria for IFG have been recently lowered from 110 to 100 mg/dl, subjects were categorized according to old (IFG 1997 ) and new (IFG 2003 ) criteria. IR and Hhcy were defined by the upper quartile of insulin (11.0 UI/L) and Hcy (18.6 mmol/L) distribution, respectively. The frequency of IFG 1997 , Hhcy, and IR, but not of IFG 2003 , showed a linear trend across tertiles of MMSE (p < 0.001). The odds ratio (95% CI) for impaired CF (MMSE < 24.3) was 9.08 (2.97e 27.74) for IFG 1997 , 3.66 (1.28e10.45) for Hhcy, 2.83 (1.25e6.37) for IR and 1.32 (0.61e2.89) for IFG 2003 . Conclusions: Our study shows that IFG 1997 , Hhcy and IR are powerful metabolic markers of impaired CF among elderly people. ª 2005 Elsevier B.V. All rights reserved. * Corresponding author. Tel.: þ39 081 8552281. E-mail address: diabetologia.po54@asl2.napoli.it (P. Di Bonito). 0939-4753/$ - see front matter ª 2005 Elsevier B.V. All rights reserved. doi:10.1016/j.numecd.2005.07.011 Nutrition, Metabolism & Cardiovascular Diseases (2007) 17, 203e208 www.elsevier.com/locate/nmcd